San Diego, CA, United States of America

Raiees Andrabi

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Scripps Research Institute. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raiees Andrabi. Retrieved from https://idiyas.com/inventor/raiees-andrabi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raiees Andrabi: Innovator in B Cell Receptor Modification

Introduction

Raiees Andrabi is a notable inventor based in San Diego, California. He has made significant contributions to the field of immunology, particularly in the modification of B cell receptors. His work focuses on enhancing the immune response against various pathogens.

Latest Patents

Raiees Andrabi holds a patent for "B cell receptor modification in B cells." This patent describes methods and systems for generating engineered B cells with modified immunoglobulin genes. The modified immunoglobulin genes encode modified immunoglobulins that can exhibit high affinity for antigens, including those that are variable, such as the types of antigens found on various pathogens that can evade mammalian immune responses. He has 1 patent to his name.

Career Highlights

Andrabi is affiliated with The Scripps Research Institute, where he conducts his research. His work is pivotal in advancing our understanding of immune responses and developing potential therapeutic strategies.

Collaborations

He has collaborated with esteemed colleagues, including James Even Voss and Dennis R Burton, who share his commitment to advancing immunological research.

Conclusion

Raiees Andrabi's innovative work in B cell receptor modification represents a significant advancement in immunology. His contributions have the potential to enhance the effectiveness of immune responses against various pathogens.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…